Trilogy Capital’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-274,481
Closed -$2.71M 287
2023
Q3
$2.71M Buy
274,481
+8,485
+3% +$88.4K 0.18% 77
2023
Q2
$2.79M Buy
265,996
+24,686
+10% +$236K 0.18% 82
2023
Q1
$2.32M Buy
241,310
+216,159
+859% +$2.4M 0.16% 86
2022
Q4
$280K Buy
25,151
+4,565
+22% +$47.7K 0.02% 216
2022
Q3
$175K Buy
20,586
+3,460
+20% +$34.1K 0.02% 177
2022
Q2
$179K Buy
17,126
+6,148
+56% +$67.4K 0.02% 158
2022
Q1
$119K Buy
+10,978
New +$145K 0.01% 166
2018
Q3
Sell
-50
Closed -$2K 659
2018
Q2
$2K Sell
50
-48
-49% -$1.88K ﹤0.01% 480
2018
Q1
$4K Buy
+98
New +$4.18K ﹤0.01% 337

Other funds holding VTRS

Trilogy Capital's VTRS Position: Q4 2023 in Review

Trilogy Capital sold out of Viatris (VTRS) in Q4 2023, closing a stake of 274,481 shares — an estimated $2.71M sold.

Trilogy Capital first reported a position in VTRS in Q1 2018 and held it in 9 quarters. The position peaked at $2.79M in Q2 2023. 1,014 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Trilogy Capital reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Trilogy Capital sold 274,481 Viatris shares in Q4 2023, an estimated $2.71M.
  • Trilogy Capital first reported a position in Viatris in Q1 2018 and held it in 9 quarters.
  • Trilogy Capital's Viatris position peaked at $2.79M in Q2 2023.
  • 1,014 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Trilogy Capital's 13F filing for Q4 2023, filed 12 Jan 2024.